[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"cost-effectiveness\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:cost-effectiveness":204},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,9,0,[8,51,86,131,163,189,214,244,274],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":34,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":50},"100643674","from-exercise-oncology-research-to-clinical-practice-100643674",false,"NCT07635589","From Exercise Oncology Research to Clinical Practice","Bridging the Gap Between Exercise Oncology Research and Its Implementation in Clinical Practice","PAC ICare","Inclusion Criteria:\n\n* Have received a cancer diagnosis (inclusive of primary, recurrent; and\u002For metastatic disease);\n* Over the age of 19 years;\n* Able to participate in mild levels of activity as a minimum;\n* Be pretreatment, or receiving active cancer treatment, or have received cancer treatment within the past six months and are still under active oncology care, or beyond six months if they continue to be under active oncology care;\n* Able to provide informed written consent in English; and\n* Have access to internet service and a device that can support video calling (for online programs).\n\nExclusion Criteria:\n\n* Severe cognitive, physical, psychiatric, or uncontrolled medical condition(s) resulting in an inability to provide consent and\u002For safely participate in the study.","ALL","19 Years",{"count":20,"type":21},500,"ESTIMATED","INTERVENTIONAL",[24],"NA","Building on previous research that shows the benefits of exercise, this study aims to find out how best to implement exercise in real-world settings. The study will assess the feasibility and acceptability of an embedding an automated referral tool and an exercise professional into standard cancer care impacts clinician referral and patient uptake of exercise programming. The study will assess how effective the exercise program is at improving patients' physical health, quality of life, symptom management, and overall wellbeing during different stages of their cancer journey (e.g., before treatment, on treatment, after treatment).",[27,28,29,30,31,32,33],"Cancer","Exercise","Implementation of Evidence Based Programs","Cost Effectiveness","Rehabilitation Exercise","Prehabilitation","Survivorship",[27,28,35,36,37,30],"Implementation Science","Mixed-Methods","Effectiveness-Implementation","NOT_YET_RECRUITING","2026-06-03",{"date":41,"type":42},"2026-06-09","ACTUAL",{"date":44,"type":21},"2026-09-01",{"date":46,"type":21},"2029-12",{"name":48,"class":49},"Melanie Keats","OTHER",1,{"id":52,"slug":53,"hasResults":11,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":57,"eligibilityCriteria":58,"healthyVolunteers":11,"sex":59,"minAge":60,"maxAge":4,"enrollmentInfo":61,"targetDuration":4,"studyType":22,"phases":63,"briefSummary":64,"conditions":65,"keywords":70,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":85},"100631175","decision-aid-for-women-newly-diagnosed-with-breast-cancer-100631175","NCT07497256","Decision Aid for Women Newly Diagnosed With Breast Cancer","Effectiveness and Cost-effectiveness of a Multimodal Shared Decision-Making Decision Aid ( BCT Aid) for Women Newly Diagnosed With Breast Cancer","BCT Aid","Inclusion Criteria:\n\n1. Age ≥ 18 years.\n2. Newly diagnosed with breast cancer, with clinical stage 0-II, or stage III eligible for breast-conserving surgery after neoadjuvant chemotherapy.\n3. Clinically eligible for breast-conserving surgery and considering one of the following surgical options: breast-conserving surgery, mastectomy, or mastectomy with reconstruction.\n4. Clinically eligible for adjuvant therapy after surgery.\n5. Able to access the internet via smartphone.\n6. Able to read, speak, and understand Mandarin.\n\nExclusion Criteria:\n\n1. Male breast cancer patients.\n2. Clinically eligible for only one surgical option or not candidates for surgery.\n3. Have a history of other malignancies, except adequately treated cervical carcinoma in situ and basal cell carcinoma of the skin.\n4. Presence of psychiatric disorders, visual or hearing impairments, or cognitive impairment.","FEMALE","18 Years",{"count":62,"type":21},160,[24],"The goal of this multi-center randomized controlled trial is to determine if the clinical decision aid (BCT Aid) works to help breast cancer patients participate in decision-making and make high-quality decisions, thereby improving the rate of breast-conserving surgery and quality of life. The main questions it aims to answer are:\n\nDoes the BCT Aid significantly increase the rate of breast-conserving surgery compared to usual care? Does the BCT Aid reduce decision conflict and decision regret, while improving shared decision-making and quality of life? Does the BCT Aid demonstrate better cost-effectiveness in terms of health resource utilization? Researchers will compare the BCT Aid to usual care (standard clinical consultation) to evaluate the effectiveness and cost-effectiveness of BCT Aid.\n\nParticipants will:\n\nBe randomly assigned to either the intervention group (receiving the BCT Aid intervention for 6 months) or the control group (usual care).\n\nComplete assessments including decision conflict and shared decision-making at baseline (T0), post-consultation with the surgeon (T1), 6 months (T2, post-intervention), and 12 months (T3, 6 months post-intervention), decision regret at T2 and T3, and quality of life at T0, T2, and T3, with additional EQ-5D-5L measurements at baseline, 3, 6, 9, and 12 months for cost-effectiveness analysis.\n\nHave clinical outcomes (breast-conserving surgery rate) and health resource utilization data collected from medical records.",[66,67,68,30,69],"Breast Cancer","Decision Aid","Shared Decision Making","Quality of Life",[71,72,73,74,75],"breast cancer","decision aid","decision conflict","shared decision making","cost effectiveness","2026-04-26",{"date":78,"type":42},"2026-04-30",{"date":80,"type":21},"2026-04-01",{"date":82,"type":21},"2027-10",{"name":84,"class":49},"Xiamen University",3,{"id":87,"slug":88,"hasResults":11,"nctId":89,"briefTitle":90,"officialTitle":90,"acronym":4,"eligibilityCriteria":91,"healthyVolunteers":92,"sex":17,"minAge":93,"maxAge":94,"enrollmentInfo":95,"targetDuration":4,"studyType":22,"phases":97,"briefSummary":98,"conditions":99,"keywords":111,"overallStatus":119,"whyStopped":4,"lastUpdateSubmitDate":120,"lastUpdatePostDateStruct":121,"startDateStruct":123,"completionDateStruct":125,"leadSponsor":127,"locationsCount":130},"100636162","develop-and-evaluate-an-artificial-intelligence-assisted-prehabilitation-program-for-returning-to-work-and-cost-effectiveness-analysis-in-patients-with-oral-cancer-100636162","NCT07562100","Develop and Evaluate An Artificial Intelligence Assisted Prehabilitation Program for Returning to Work and Cost-effectiveness Analysis in Patients With Oral Cancer","Inclusion Criteria:\n\n* Adult (\\> 20 years old and younger than 70 years old)\n* Newly diagnosed as OC and scheduled to receive cancer-related treatment\n* Able to use Mobile phone\n* Willing to sign an informed consent form after receiving a detailed explanation of the study's aims and procedures\n* Healthcare professionals involved in patients' care, including doctors, nurses, case managers, dietitians, rehabilitation therapists, and psychologists\n* Family members who are primary caregivers of the participating patients, engaged in different stages of medical care\n\nExclusion Criteria:\n\n* Risk populations for walking or performing exercise\n* Patients with cognitive impairment or psychiatric diseases",true,"20 Years","70 Years",{"count":96,"type":21},650,[24],"The goal of this clinical trial is to develop and evaluate an Artificial Intelligence Assisted Prehabilitation Program (AI APP) for returning to work and cost-effectiveness analysis in patients with oral cancer (OC). The main questions it aims to answer are:\n\n* What kinds of needs are related to returning to work (RTW) in patients with OC from diagnosis to survival that we can incorporate into the development of AI APP to assist this population ?\n* How is the effect of the AI APP that based on findings from the first question for patients with OC on physical and psychological distress, fear of recurrence, self-efficacy in coping with cancer, communication, motor function, quality of life, and RTW?\n* How is the effect of the RTW AI prediction model to identify high-risk groups ? And how is the comprehensive cost effectiveness of benefits and quality of life of the AI APP for OC population?\n\nResearchers will compare patients without using AI APP to see if the AI APP works to assist with coping physical and psychological distress, communication, motor function, quality of life, and RTW issues for individuals with OC?\n\nParticipants will:\n\n* Be asked to fulfill a structural questionnaire, or engage in a semi-structured one-by-one interview or a focus group to assess their physical, psychological, and social support needs in the first stage.\n* Be invited to participant the pilot testing of AI APP in the second stage.\n* Be provided and trained by 3-month AI APP for 3 months or cared as usual in the third stage.\n* Complete a structural questionnaire and follow up one year, including the baseline (before using the AI app) and at 1-2 weeks, 3 months, 6 months, 9 months, and 12 months after the baseline.\n* Engage in one-by-one interview or a focus group to assess user experiences of the AI APP.",[100,101,102,103,104,32,105,106,107,69,30,108,109,110],"Oral Cancer","Psychological Distress","Communication Aids for Disabled","Physiotherapy","Return to Work","Physical Symptom Distress","Motor Function","Rehabilitation","Artifical Intelligence","Prediction Model","Case Management, APP(Application)",[112,104,100,101,102,103,32,113,114,107,115,116,117,118],"Artificial Intelligence","Physical symptom distress","motor function","Quality of life","Cost effectiveness","prediction model","case management, APP(Application)","RECRUITING","2026-04-24",{"date":122,"type":42},"2026-05-01",{"date":124,"type":42},"2024-09-27",{"date":126,"type":21},"2029-12-01",{"name":128,"class":129},"Taipei Veterans General Hospital, Taiwan","OTHER_GOV",5,{"id":132,"slug":133,"hasResults":11,"nctId":134,"briefTitle":135,"officialTitle":136,"acronym":137,"eligibilityCriteria":138,"healthyVolunteers":92,"sex":17,"minAge":139,"maxAge":140,"enrollmentInfo":141,"targetDuration":4,"studyType":22,"phases":143,"briefSummary":144,"conditions":145,"keywords":149,"overallStatus":119,"whyStopped":4,"lastUpdateSubmitDate":154,"lastUpdatePostDateStruct":155,"startDateStruct":157,"completionDateStruct":159,"leadSponsor":161,"locationsCount":50},"100619946","pediatric-airway-noninferiority-trial-of-devices-for-intubation-assessment-100619946","NCT07351227","Pediatric Airway: Noninferiority Trial of Devices for Intubation Assessment","Comparison of the Effectiveness and Cost-Effectiveness of McGRATH™ MAC and Besdata Videolaryngoscopes in the Orotracheal Intubation of Children: A Non-Inferiority Randomized Clinical Trial","PANDA","Inclusion Criteria:\n\n* The study will include children aged between 6 months and 3 years who are scheduled for elective surgery under general anesthesia at the Children's Institute (Instituto da Criança - ICr) of the Hospital das Clínicas Complex, University of São Paulo Medical School (HC-FMUSP), provided that informed consent is obtained from their parents or legal guardians.\n\nExclusion Criteria:\n\n* Patients under one year of age will be excluded if informed consent is not obtained from their legal guardians, if they are classified as ASA physical status IV or higher, present with hemodynamic instability, or have craniofacial abnormalities or oral deformities suggestive of a potentially difficult airway.","6 Months","3 Years",{"count":142,"type":21},226,[24],"The goal of this clinical trial is to find out whether the BESDATA BD-DF videolaryngoscope works as well as the McGRATH™ MAC videolaryngoscope for placing a breathing tube in infants during surgery. The study will also compare the costs associated with using each device.\n\nThe main questions this study aims to answer are:\n\nIs the BESDATA BD-DF videolaryngoscope as effective as the McGRATH™ MAC videolaryngoscope for successful placement of a breathing tube on the first attempt in infants?\n\nAre there differences between the two devices in terms of procedure time, number of attempts, airway-related complications, and overall costs?\n\nResearchers will compare infants who are intubated using the BESDATA BD-DF videolaryngoscope with infants who are intubated using the McGRATH™ MAC videolaryngoscope to see whether the two devices perform similarly and whether one is more cost-effective than the other.\n\nParticipants will:\n\nBe randomly assigned to have a breathing tube placed using one of the two videolaryngoscopes;\n\nReceive standard general anesthesia for an elective surgical procedure;\n\nHave information collected during and after the procedure to assess safety, effectiveness, and costs.",[146,147,148,30],"Intubation, Intratracheal","Airway Management","Video Laryngoscope",[150,151,116,152,153],"Videolaryngoscope","Pediatric orotracheal intubation","McGrath MAC","BESDATA","2026-03-18",{"date":156,"type":42},"2026-03-20",{"date":158,"type":42},"2026-03-01",{"date":160,"type":21},"2027-12-31",{"name":162,"class":49},"University of Sao Paulo General Hospital",{"id":164,"slug":165,"hasResults":11,"nctId":166,"briefTitle":167,"officialTitle":168,"acronym":169,"eligibilityCriteria":170,"healthyVolunteers":92,"sex":59,"minAge":60,"maxAge":171,"enrollmentInfo":172,"targetDuration":4,"studyType":22,"phases":174,"briefSummary":175,"conditions":176,"keywords":4,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":180,"lastUpdatePostDateStruct":181,"startDateStruct":183,"completionDateStruct":185,"leadSponsor":187,"locationsCount":4},"100581776","impact-of-implementing-the-midwifery-model-of-care-on-maternal-and-neonatal-health-outcomes-in-ethiopia-100581776","NCT06854705","Impact of Implementing the Midwifery Model of Care on Maternal and Neonatal Health Outcomes in Ethiopia","Remodeling Maternal Health Care: Evaluating the Impact of Implementing the Midwifery Model of Care on Maternal and Neonatal Health Outcomes in Ethiopia (MiMoC Project)","MiMoC","Inclusion Criteria:\n\n* All sampled pregnant women above 18 years with gestational age less than 24 whole weeks at the first ANC booking at the Government Hospitals\n* Singleton pregnancy, and\n* low obstetric risk.\n\nExclusion Criteria:\n\n* Women who plan to have an elective cesarean section or\n* Women who have a history of medical or obstetric complications.\n* pregnant women who are unable to provide valid information due to mental, hearing, speech, or other medical issues that could worsen their current pregnancy will also be excluded.\n* pregnant mothers who are temporary residents and are expected to leave the study area before the 42-day postpartum period.\n* Women with a history of medical and obstetrics complications.","49 Years",{"count":173,"type":21},1654,[24],"Background: The Continuity of Midwifery Care (CoMC) is a maternity care model used in some high-income countries. In this model, a dedicated group of midwives supports women throughout pregnancy, labor, and the early postnatal period. This model has been shown to improve maternal and neonatal outcomes and enhance maternal satisfaction. However, its effectiveness in low-and middle-income countries remains uncertain.\n\nPurpose and Aim of the Study: This study aims to evaluate whether CoMC, supported by midwife-led birthing centers, improves maternal and neonatal health outcomes compared to the standard care model in Ethiopia.\n\nResearch Question: Does the CoMC model, integrated with midwife-led birthing centers, enhance maternal and neonatal outcomes compared to the standard maternal health care model? Additionally, does its implementation strengthen midwives' capacity to deliver quality care and increase the uptake of evidence-based practices in Ethiopia? Methods: A hybrid implementation-effectiveness, randomized, controlled, unblinded, parallel-group pilot trial will be conducted. The type 2 hybrid design will equally emphasize effectiveness and implementation outcomes. The study will take place in four randomly selected hospitals in the North Shoa Zone, Amhara regional state, Ethiopia, involving 1,654 pregnant women (\\\u003C20 weeks gestation at first ANC visit). Participants will be randomly assigned to CoMC (Group A) or standard care (Group B) using a computer-generated scheme. Midwives will be organized into teams following the CoMC model. Women will receive study information during ANC visits and, if interested, will discuss participation with the CoMC team leader. Upon consent, they will be randomly allocated using a secure computerized system.\n\nIn the CoMC arm, women will receive care from a single midwife or a backup midwife throughout pregnancy, labor, birth, and the immediate postnatal period. In the standard care arm, multiple staff members will provide care at different times.\n\nOutcomes: The primary maternal outcome is the proportion of women achieving spontaneous vaginal birth. The primary neonatal outcome is the proportion of neonates experiencing preterm birth. These outcomes will be analyzed using bivariable and multivariable generalized linear models (GLMs) with 95% confidence intervals.",[177,178,179,30],"Midwifery Continuity of Care Model","Maternal Health Outcomes","Neonatal Health Outcomes","2025-02-25",{"date":182,"type":42},"2025-03-03",{"date":184,"type":21},"2025-02-24",{"date":186,"type":21},"2026-02-23",{"name":188,"class":49},"Debre Berhan University",{"id":190,"slug":191,"hasResults":11,"nctId":192,"briefTitle":193,"officialTitle":194,"acronym":4,"eligibilityCriteria":195,"healthyVolunteers":11,"sex":59,"minAge":93,"maxAge":4,"enrollmentInfo":196,"targetDuration":4,"studyType":22,"phases":198,"briefSummary":199,"conditions":200,"keywords":4,"overallStatus":119,"whyStopped":4,"lastUpdateSubmitDate":205,"lastUpdatePostDateStruct":206,"startDateStruct":208,"completionDateStruct":210,"leadSponsor":212,"locationsCount":50},"100563233","effectiveness-of-the-ai-supporter-in-reducing-urinary-tract-infections-100563233","NCT06613503","Effectiveness of the AI-Supporter in Reducing Urinary Tract Infections","Testing the Effectiveness of the AI-Supporter in Reducing Urinary Tract Infections, Incontinence-associated Dermatitis and Caregiving Costs for Incontinence Patients","Inclusion Criteria:\n\n* Participants must have been bedridden for at least 3 months and have urinary and\u002For fecal incontinence.\n* Female participants aged over 20 years old.\n* Participants must be capable of wearing the AI-supporter device during the study period.\n\nExclusion Criteria:\n\n* Participants with severe skin conditions unrelated to incontinence.\n* Participants with current urinary tract infections or incontinence-associated dermatitis at the time of enrollment.\n* Participants who are unable to provide informed consent or have a legal representative to do so.",{"count":197,"type":21},60,[24],"The \"AI Supporter,\" an intelligent excretion management robot, leverages artificial intelligence-based vision recognition to autonomously detect and cleanse affected areas, followed by drying and changing the diaper, thereby reducing caregiver strain and enhancing care quality. This study aims to assess the efficacy of the \"AI Supporter\" in decreasing the incidence of urinary tract infections and incontinence-associated dermatitis among incontinent patients, in addition to exploring its cost-effectiveness.\n\nAdopting an experimental (two groups) and longitudinal design, this research utilizes both convenience and random sampling strategies. The study anticipates recruiting 60 female subjects who have been confined to bed for more than three months with urinary and\u002For fecal incontinence. Participants will intermittently use the AI Supporter over a 14-day period. Measurement tools include routine urine analysis.",[201,202,203,204],"Incontinence","Urinary Tract Infection","Incontinence-associated Dermatitis","Cost-effectiveness","2024-09-23",{"date":207,"type":42},"2024-09-26",{"date":209,"type":42},"2024-07-22",{"date":211,"type":21},"2025-10-31",{"name":213,"class":49},"China Medical University Hospital",{"id":215,"slug":216,"hasResults":11,"nctId":217,"briefTitle":218,"officialTitle":219,"acronym":220,"eligibilityCriteria":221,"healthyVolunteers":11,"sex":17,"minAge":60,"maxAge":4,"enrollmentInfo":222,"targetDuration":4,"studyType":22,"phases":224,"briefSummary":225,"conditions":226,"keywords":4,"overallStatus":119,"whyStopped":4,"lastUpdateSubmitDate":235,"lastUpdatePostDateStruct":236,"startDateStruct":238,"completionDateStruct":240,"leadSponsor":241,"locationsCount":243},"100536111","home-based-exercise-and-physical-activity-intervention-after-kidney-transplantation-impact-of-exercise-intensity-100536111","NCT06260579","Home-based Exercise and Physical Activity Intervention After Kidney Transplantation: Impact of Exercise Intensity","A Home-based Exercise and Physical Activity Intervention After Kidney Transplantation: Impact of Exercise Intensity - a Multicenter Randomized Controlled Trial","PHOENIX-Kidney","Inclusion Criteria:\n\nDe novo adult KTRs\n\nExclusion Criteria:\n\n* Underlying heart disease, defined as aberrant CPET, unstable angina, non-revascularized lesions or life-threatening arrhythmias\n* Uncontrolled hypertension\n* Uncontrolled diabetes, defined as HbA1c ≥ 9%\n* Musculoskeletal disorders not allowing physical training on a cycle ergometer, or any other medical reasons by the physician considered to be a contraindication for moderate or high-intensity physical exercise\n* Multi-organ transplantation\n* Ongoing treatment for malignancies\n* Unable to understand Dutch\n* No access to smartphone and\u002For computer with internet access\n* Severe pulmonary disease defined as either forced vital capacity (FVC) \\\u003C50%, one-second value (FEV1) \\\u003C50%, or a diffusing capacity for carbon monoxide (DLCO) \\\u003C40% that excludes all serious underlying respiratory disease (pulmonary fibrosis, COPD GOLD II-IV, PAH).",{"count":223,"type":21},147,[24],"This multicentre two-phased RCT aims to evaluate implementation potential, cost-effectiveness, effectiveness, and the role of exercise intensity of a home-based exercise and physical activity intervention to improve de novo kidney transplant recipients' physical fitness, cardiovascular health, gut microbiome characteristics, and health-related quality of life. The first phase of this study comprehends a six-month exercise training intervention. Patients will be randomized into (i) a sham intervention consisting of low-intensity balance and stretching exercises (LIT), (ii) a moderate-intensity aerobic and strength training intervention (MIT), or (iii) a moderate- and high-intensity aerobic and strength training intervention (MHIT). The second phase of this study comprehends a physical activity maintenance intervention provided to MIT and MHIT but not LIT. A total of 147 de novo kidney transplant recipients will be recruited from two independent Belgian transplant centres i.e. UZ Leuven and UZ Ghent.",[227,228,229,230,231,232,233,234,204],"Physical Activity","Exercise Training","Kidney Transplantation","Physical Fitness","Cardiovascular Health","Gut Microbiome","Health-related Quality of Life","Implementation","2024-02-07",{"date":237,"type":42},"2024-02-15",{"date":239,"type":42},"2022-11-14",{"date":46,"type":21},{"name":242,"class":49},"KU Leuven",2,{"id":245,"slug":246,"hasResults":11,"nctId":247,"briefTitle":248,"officialTitle":249,"acronym":4,"eligibilityCriteria":250,"healthyVolunteers":92,"sex":17,"minAge":60,"maxAge":251,"enrollmentInfo":252,"targetDuration":4,"studyType":22,"phases":254,"briefSummary":255,"conditions":256,"keywords":258,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":265,"lastUpdatePostDateStruct":266,"startDateStruct":268,"completionDateStruct":270,"leadSponsor":272,"locationsCount":50},"100327919","effects-of-patient-centered-telephone-education-in-day-surgery-100327919","NCT03549403","Effects of Patient-centered Telephone Education in Day Surgery","Effects of Patient-centered Pre- and Postoperative Telephone Education on the Experienced Health and Health-care Costs in Day Surgery by Adult Patients: A Randomized Controlled Trial.","Inclusion Criteria:\n\n* arrive at the surgery from home\n* leave latest at the next morning of the surgery\n* leave home after surgery\n* is 18-64 years old\n* be able to respond to the questionnaire independently.\n\nExclusion Criteria:\n\n* over 65 years old patients\n* patients who need institutional care after surgery\n* patients who arrive to surgery from a institutional care unit","64 Years",{"count":253,"type":21},120,[24],"This study describe and evaluate the effectiveness of patient-centered telephone education in day surgery. The aim is to evaluate the effects of patient-centered telephone education on the experienced health of adult patients and the costs of healthcare in day surgery. Telephone education intervention is planned in co-operation with the day surgery unit´s healthcare staff.\n\nHalf of participants will receive current education in day surgery, while the other half will receive developed patient-centered telephone education before and after day surgery.",[257,30],"Health, Subjective",[259,260,261,262,263,264],"Telephone education","Effectiveness","Health","Cost","Day surgery","Adult patient","2023-11-28",{"date":267,"type":42},"2023-11-29",{"date":269,"type":21},"2024-09-01",{"date":271,"type":21},"2026-12",{"name":273,"class":49},"University of Oulu",{"id":275,"slug":276,"hasResults":11,"nctId":277,"briefTitle":278,"officialTitle":279,"acronym":280,"eligibilityCriteria":281,"healthyVolunteers":11,"sex":17,"minAge":282,"maxAge":283,"enrollmentInfo":284,"targetDuration":4,"studyType":22,"phases":286,"briefSummary":287,"conditions":288,"keywords":4,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":293,"lastUpdatePostDateStruct":294,"startDateStruct":296,"completionDateStruct":298,"leadSponsor":300,"locationsCount":301},"100385501","urinary-proteomics-combined-with-home-blood-pressure-telemonitoring-for-health-care-reform-100385501","NCT04299529","Urinary Proteomics Combined With Home Blood Pressure Telemonitoring for Health Care Reform","Urinary Proteomics Combined With Home Blood Pressure Telemonitoring for Health Care Reform: a Randomised Controlled Trial","UPRIGHT-HTM","Inclusion Criteria:\n\n* Patients must have at least three additional guideline-defined risk factors, preferably including hypertension, type 2 diabetes mellitus (T2DM), or both;\n* Patients should be willing patients to engage for the duration of the study in home blood pressure telemonitoring (1 reading per day);\n* Patients must have an email address and internet access via smartphone, tablet, or laptop or desktop computer;\n* Patients should comply with the study protocol during the run-in phase.\n\nExclusion Criteria:\n\n* Type 1 diabetes mellitus;\n* Absence of a practicable echocardiographic window;\n* Previous or concurrent severe cardiovascular or non-cardiovascular disease;\n* Cancer within 5 years of enrolment;\n* Suspected substance abuse;\n* Psychiatric illness;\n* Use of nephrotoxic drugs;\n* Particpation in another clinical study.","55 Years","75 Years",{"count":285,"type":21},1000,[24],"UPRIGHT-HTM will compare risk stratification, treatment efficiency and health economic outcomes of a diagnostic approach based on home blood pressure telemonitoring combined with urinary proteomic profiling with home blood pressure telemonitoring alone",[289,290,291,30,292],"Protein Deregulation","Blood Pressure","Health Care Utilization","Patient Empowerment","2020-03-05",{"date":295,"type":42},"2020-03-06",{"date":297,"type":21},"2020-04-01",{"date":299,"type":21},"2026-07-31",{"name":242,"class":49},12]